These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4542950)

  • 1. Relationship between heart rate and ouabain toxicity in the dog heart-lung preparation.
    Lahiri PK; Laddu AR
    Jpn Heart J; 1973 Jul; 14(4):357-65. PubMed ID: 4542950
    [No Abstract]   [Full Text] [Related]  

  • 2. Digitalis toxicity. Development of cardiac arrhythmias in spontaneously breathing vs. artificially respired dogs.
    Stickney JL; Meyers FH
    Am Heart J; 1973 Apr; 85(4):501-5. PubMed ID: 4689502
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiarrhythmic activity of 1-(di-2,6-xylylmethoxy)-3-(isopropylamino) propanol-2-hydrochloride (BS-7977-d) in the dog heart lung preparation.
    Laddu R
    Eur J Pharmacol; 1970 Feb; 9(2):129-35. PubMed ID: 4392344
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic actions of 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172) in the dog heart-lung preparation.
    Laddu AR; Somani P
    J Pharmacol Exp Ther; 1969 Nov; 170(1):79-83. PubMed ID: 4390815
    [No Abstract]   [Full Text] [Related]  

  • 5. Ouabain-induced arrhythmia in the rabbit: effects of alpha-methyl-meta-tyrosine.
    Ciofalo FR; Treece G
    Eur J Pharmacol; 1970 Mar; 9(3):297-303. PubMed ID: 4191625
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of nonsteroidal anti-inflammatory drugs on ouabain toxicity.
    Wilkerson RD; Glenn TM
    Am Heart J; 1977 Oct; 94(4):454-9. PubMed ID: 410285
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICI 45763).
    Somani P
    Am Heart J; 1969 Jan; 77(1):63-71. PubMed ID: 5782851
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of oxyfedrine and ouabain on the heart-lung preparation of the dog.
    Sakai K; Sugano S; Isono C
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):89-102. PubMed ID: 4267600
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative blood pressure and electrocardiographic changes induced by proscillaridin and ouabain.
    Melville KI; Shister HE; Klingner B
    Can J Physiol Pharmacol; 1966 Nov; 44(6):887-92. PubMed ID: 5970231
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.
    Alkondon M; Ray A; Sen P
    J Pharm Pharmacol; 1984 Oct; 36(10):702-4. PubMed ID: 6150094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of bretylium on experimental cardiac dysrhythmias.
    Allen JD; Zaidi SA; Shanks RG; Pantridge JF
    Am J Cardiol; 1972 May; 29(5):641-9. PubMed ID: 5021494
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac toxicity of ouabain and acetylstrophanthidin: influence of afferent denervation.
    Stickney JL
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):5-15. PubMed ID: 4725339
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of propranolol on ouabain uptake by the guinea pig heart.
    Cagin N; Freeman E; Somberg JC; Bounous H; Mittag T; Diaz R; Levitt B
    Eur J Pharmacol; 1973 Nov; 24(2):256-61. PubMed ID: 4765749
    [No Abstract]   [Full Text] [Related]  

  • 14. Some factors affecting ouabain-induced ventricular arrhythmia in the reserpine-treated cat.
    Ciofalo F; Levitt B; Roberts J
    Br J Pharmacol Chemother; 1967 May; 30(1):143-54. PubMed ID: 4166977
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic potency of N-propyl ajmaline with untoward response of ventricular fibrillation in excess dose.
    Nakayama K; Koike H; Oshima T; Hashimoto K
    Jpn J Pharmacol; 1973 Feb; 23(1):9-16. PubMed ID: 4146270
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of potassium canrenoate to suppress ouabain-induced ventricular arrhythmias in dogs.
    Yeh BK; Sung PK; Saha AK
    Circ Res; 1972 Dec; 31(6):915-22. PubMed ID: 4641788
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac and respiratory effects of digitalis during chronic hypoxia in intact conscious dogs.
    Beller GA; Giamber SR; Saltz SB; Smith TW
    Am J Physiol; 1975 Aug; 229(2):270-4. PubMed ID: 240277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of cardiac arrhythmias by dl-1-(2-acetyl-4-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new beta adrenoreceptor blocking agent.
    Laddu AR
    Jpn Heart J; 1974 Jan; 15(1):61-71. PubMed ID: 4151909
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the peak inotropic effects of a catecholamine and a digitalis glycoside in the intact canine heart.
    Beiser GD; Epstein SE; Goldstein RE; Stampfer M; Braunwald E
    Circulation; 1970 Nov; 42(5):805-13. PubMed ID: 5477254
    [No Abstract]   [Full Text] [Related]  

  • 20. Bromocriptine treatment of digitalis-induced ventricular tachyarrhythmias: studies in a canine model.
    Kao A; Kriett JM; Tobler HG; Detloff BL; Pritzker MR; Benson DW; Benditt DG
    J Am Coll Cardiol; 1984 Dec; 4(6):1188-94. PubMed ID: 6501720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.